Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
---|---|---|---|---|---|---|---|---|---|
Wuxi Biologics (Cayman) | BUY HK$24.24 | ― | -7.50% | Reiterated | WuXi Biologics: Buy Rating Supported by Strong Performance, Strategic Growth, and Increased Target Price | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$17.42 | ― | 4.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$100→HK$90 | ― | 15.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$21.2 | ― | 7.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$24→HK$21.5 | ― | 7.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$7.7→HK$7.5 | ― | 7.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL HK$4.5→HK$4.1 | ― | 7.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$83→HK$76 | ― | 2.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$56→HK$64 | ― | 22.70% | Reiterated | ||||
China Tourism Group Duty Free Corporation Limited Class H | HOLD HK$58→HK$50 | ― | -6.20% | Reiterated | China Tourism Group Duty Free Corp (1880:HK) PT Lowered to HK$50 at Goldman SachsGoldman Sachs analyst Simon Cheung lowered the price target on China Tourism Group Duty Free Corp (1880:HK) to HK$50.00 (from HK$58.00) while maintaining a Neutral rating. | ||||
Tingyi (Cayman Islands) Holding | BUY HK$10.6→HK$13 | ― | -1.40% | Upgraded | Goldman Sachs Upgrades Tingyi Cayman Islands Holding Corp. (322:HK) (TCYMY) to BuyGoldman Sachs analyst Christine Cho upgraded Tingyi Cayman Islands Holding Corp. (322:HK) (OTC: TCYMY) from Neutral to Buy with a price target of HK$13.00 (from HK$10.60). | ||||
ZJLD Group, Inc. | BUY HK$10.4→HK$8.2 | ― | -10.20% | Reiterated | ZJLD Group Inc (6979:HK) PT Lowered to HK$8.20 at Goldman SachsGoldman Sachs analyst Leaf Liu lowered the price target on ZJLD Group Inc (6979:HK) to HK$8.20 (from HK$10.40) while maintaining a Buy rating. | ||||
Wharf Real Estate Investment Co | BUY HK$23.26 | ― | -8.10% | Reiterated | DBS Keeps Their Buy Rating on Wharf Real Estate Investment Co (WRFRF) | ||||
Fortune Real Estate Investment | BUY HK$4.95 | ― | -8.10% | Reiterated | DBS Reaffirms Their Buy Rating on Fortune Real Estate Investment (FRIVF) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$562→HK$560 | ― | 2.10% | Reiterated | ||||
Haidilao International Holding | BUY HK$15.1→HK$16.3 | ― | -23.50% | Reiterated | Haidilao International Holding Ltd. (6862:HK) (HDALF) PT Raised to HK$16.30 at Nomura/InstinetNomura/Instinet analyst Cathy Xiao raised the price target on Haidilao International Holding Ltd. (6862:HK) (OTC: HDALF) to HK$16.30 (from HK$15.10) while maintaining a Buy rating. | ||||
BOE Varitronix | BUY HK$5.6→HK$8.5 | ― | -2.80% | Reiterated | BOE Varitronix Ltd (710:HK) PT Raised to HK$8.50 at CitiCiti analyst Kyna Wong raised the price target on BOE Varitronix Ltd (710:HK) to HK$8.50 (from HK$5.60) while maintaining a Buy rating. | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL HK$2.6→HK$1.7 | ― | 0.90% | Downgraded | ||||
Johnny YumUOB Kay Hian Not Ranked | Lenovo Group | BUY HK$12 | ― | ― | Reiterated | Lenovo's Growth Potential Driven by AI Integration and Market Expansion | |||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$8.5 | ― | 5.80% | Initiated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$6.79 | ― | 39.40% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$36→HK$34 | ― | 9.20% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$34→HK$31 | ― | 9.20% | Reiterated | ||||
Longfor Group Holdings | BUY HK$16→HK$11.7 | ― | -1.90% | Reiterated | DBS Remains a Buy on Longfor Group Holdings (LNGPF) | ||||
Brian HoBernstein Not Ranked | Tianqi Lithium Corp. Class H | BUY HK$40 | ― | ― | Assigned | Bernstein Remains a Buy on Tianqi Lithium Corp. Class H (9696) | |||
Tencent Holdings Limited | BUY HK$570→HK$550 | ― | -10.00% | Reiterated | Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$550 at Morgan StanleyMorgan Stanley analyst Gary Yu lowered the price target on Tencent Holdings (700:HK) (OTC: TCEHY) to HK$550.00 (from HK$570.00) while maintaining a Overweight rating. | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$5.4 | ― | 16.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$122→HK$124 | ― | 1.00% | Reiterated | ||||
Health and Happiness (H&H) International Holdings | BUY HK$9.4 | ― | -15.10% | Reiterated | Jefferies Keeps Their Buy Rating on Health and Happiness (H&H) International Holdings (BTSDF) | ||||
Li Ning Company | BUY HK$20.9→HK$20.3 | ― | -23.50% | Reiterated | Li Ning Co. Ltd. (2331:HK) (LNNGF) PT Lowered to HK$20.30 at Nomura/InstinetNomura/Instinet analyst Cathy Xiao lowered the price target on Li Ning Co. Ltd. (2331:HK) (OTC: LNNGF) to HK$20.30 (from HK$20.90) while maintaining a Buy rating. | ||||
Sunny Optical Technology (Group) Co | BUY HK$67→HK$77 | ― | -2.10% | Reiterated | Sunny Optical Technology Group Co Ltd (2382:HK) (SNPTF) PT Raised to HK$77 at CitiCiti analyst Mark Li raised the price target on Sunny Optical Technology Group Co Ltd (2382:HK) (OTC: SNPTF) to HK$77.00 (from HK$67.00) while maintaining a Buy rating. | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$64→HK$56 | ― | 4.00% | Reiterated | ||||
AAC Technologies Holdings | BUY HK$41→HK$46 | ― | -32.80% | Reiterated | AAC Technologies Holdings Inc. (2018:HK) (AACAY) PT Raised to HK$46 at CitiCiti analyst Arthur Lai raised the price target on AAC Technologies Holdings Inc. (2018:HK) (OTC: AACAY) to HK$46.00 (from HK$41.00) while maintaining a Buy rating. | ||||
Xiaomi | BUY HK$34.9→HK$41 | ― | -2.80% | Reiterated | Xiaomi Corp (1810:HK) (XIACF) PT Raised to HK$41 at CitiCiti analyst Kyna Wong raised the price target on Xiaomi Corp (1810:HK) (OTC: XIACF) to HK$41.00 (from HK$34.90) while maintaining a Buy rating. | ||||
Everest Medicines Ltd. | BUY HK$25→HK$40 | ― | -2.70% | Reiterated | Everest Medicines Ltd (1952:HK) PT Raised to HK$40 at CitiCiti analyst Wangbin Zhou raised the price target on Everest Medicines Ltd (1952:HK) to HK$40.00 (from HK$25.00) while maintaining a Buy rating. | ||||
Kingdee International Software Group Co | BUY HK$8.9→HK$12.4 | ― | -2.80% | Reiterated | Kingdee Int'l Software Group Co. (268:HK) (KGDEF) PT Raised to HK$12.40 at CitiCiti analyst Kyna Wong raised the price target on Kingdee Int'l Software Group Co. (268:HK) (OTC: KGDEF) to HK$12.40 (from HK$8.90) while maintaining a Buy rating. | ||||
Q Technology (Group) Co | BUY HK$4.6→HK$7.1 | ― | -2.10% | Upgraded | Citi Upgrades Q Technology Group Co Ltd. (1478:HK) to BuyCiti analyst Mark Li upgraded Q Technology Group Co Ltd. (1478:HK) from Neutral to Buy with a price target of HK$7.10 (from HK$4.60). | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$6.3→HK$5.2 | ― | 4.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL HK$2.85→HK$2.4 | ― | 4.00% | Reiterated | ||||
Samantha ChinCLSA Not Ranked | CK Infrastructure Holdings | BUY HK$60→HK$62 | ― | ― | Reiterated | CK Infrastructure Holdings (1038:HK) (CKISY) PT Raised to HK$62 at CLSACLSA analyst Samantha Chin raised the price target on CK Infrastructure Holdings (1038:HK) (OTC: CKISY) to HK$62.00 (from HK$60.00) while maintaining a Outperform (2) rating. | |||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$14.5 | ― | 3.50% | Reiterated | ||||
Hysan Development Co | BUY HK$14.38 | ― | -8.10% | Reiterated | DBS Sticks to Its Buy Rating for Hysan Development Co (HYSNF) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY HK$135.5→HK$133.1 | ― | 2.10% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD HK$20.3→HK$16.8 | ― | 2.70% | Downgraded |